14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:ARDM
Delisted

Aradigm Corporation Stock Signals

$0.0500
+0 (+0%)
At Close: Sep 04, 2020

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 38 days ( 0 % )
Last Price $0.0500 0 %
High/ Low $0.0500 - $0.0500 0%
Chg 7 Days N/A $0.0500 $0.0500
Chg 30 Days N/A $0.0500 $0.0500
Chg 12 mos -67.74 % $0.155 $0.0500
Trend - 3 mos -3.91 % Width: 62.12 %
Trend - 12 mos -44.11 % Width: 354.49 %
Pred. range - 3 mos $0.0377 - $0.0611 -24.68 % - 22.11 %
Pred. range - 12 mos N/A - $0.0610 -100.00 % - 22.10 %
Short MA avg 3 mos Sell Jun 26, 2020 - 50 days
Long MA avg 3 mos Buy Jul 27, 2020 - 30 days
Short/Long MA avg 3 mos Buy Jul 27, 2020 - 30 days
Short MA avg 12 mos Sell Jun 26, 2020 - 50 days
Long MA avg 12 mos Buy Jul 10, 2020 - 41 days
Short/Long MA avg 12 mos Buy Jul 13, 2020 - 40 days
Pivot Short Sell Sep 03, 2020 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Aradigm Corporation

Aradigm Corporation, a specialty pharmaceutical company, focuses on the development and commercialization of drugs delivered by inhalation for the prevention and treatment of severe respiratory diseases. The company’s lead development candidates are proprietary formulations of the potent antibiotic ciprofloxacin (Pulmaquin (ARD-3150) and Lipoquin (ARD-3100)) that are delivered by inhalation for the management of infections associated with severe... ARDM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT